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Abstract 
Serotonergic mechanisms mediate the expression of personality traits linked to 
vulnerability to psychological illness such as impulsivity, aggression and anxiety; 
and modulate the identification of emotional expressions in the face as well as 
emotional learning about broader classes of appetitive and aversive signals. Faces 
with neutral expressions signal a variety of socially-relevant information, such that 
inferences about the big-five personality traits, including Neuroticism, Extraversion, 
and Agreeableness, can be accurately made on the basis of emotionally neutral facial 
photographs. Given the close link between Neuroticism and psychological distress, 
anxiety and depression, we investigated the effects of diminished central serotonin 
activity (achieved by tryptophan depletion) upon the accuracy of 52 healthy (non-
clinical) adults discriminations of personality from facial characteristics. All 
participants were able to discriminate reliably four of the big-five traits, including 
Neuroticism. However, the tryptophan-depleted participants were specifically less 
accurate in discriminating Neuroticism than the matched non-depleted participants. 
These data suggest that central serotonin activity modulates the identification of, not 
only negative facial emotional expression, but a broader class of signals about 
personality characteristics linked to psychological distress.  
 
Keywords: serotonin; personality; Neuroticism; psychological distress 
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Introduction 
 
Serotonin mechanisms mediate the expression of personality traits linked to mental 
illnesses, including impulsivity, aggression and Neuroticism (Takano et al, 2007). 
High levels of Neuroticism have been associated with increased 5-HTT binding 
within the thalamus (Takano et al, 2007), while a number of characteristic emotional 
experiences associated with Neuroticism, such as anxiety, depression, hopelessness, 
somatization, guilt, hostility, and affective temperament – have been linked to  the 5-
HTTPLR polymorphism of the serotonin transporter gene (Gonda et al, 2009).  
However, to date, there have been no investigations of the role of serotonin activity 
in the identification of Neuroticism and other aspects of personality in other people. 
   
Other evidence attests to the role of serotoninergic mechanisms in the recognition of 
facial expressions of emotion including, but not limited to, fearful states (Harmer, 
Rogers, Tunbridge & Goodwin. 2003). Tryptophan depletion – producing temporary 
reductions in central serotonin activity (Moore, Landolt, Seifritz, Clark, Bhatti, 
Kelsoe, Rapaport, & Gillin, 2000) – impairs the accuracy of fear recognition in 
healthy females, and slows latencies for the recognition of fearful expressions in both 
healthy (non-clinical) male and female adults (Harmer et al, 2003). By contrast, 
single doses of the selective serotonin reuptake inhibitor (SSRI), citalopram, improve 
fear recognition in healthy adults (Browning et al, 2007) and normalizes recognition 
of fearful (and positive) facial expressions in previously depressed individuals 
(Bhagwagar et al, 2004). These effects are likely to be mediated by altered signaling 
within neural circuitry encompassing the amygdala (Harmer, Shelly, Cowen, & 
Goodwin, 2004), suggesting that anti-depressant modulation of monoaminergic 
activity within limbic circuits alters sensitivity to facial emotional signals (as well as 
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broader cognitive biases) to support their delayed therapeutic effects (Anderson, 
Juhasz, Thomas, Downey, McKie, Deakin, & Elliott, 2011; Booij & Van der Does, 
2011; Hayward,  Goodwin, Cowen & Harmer, 2005; Harmer, Mackay, Reid, Cowen, 
& Goodwin, 2006; Walsh & Harmer, 2015). However, beyond emotional 
expressions, the face transmits a variety of other informative cues to social traits. In 
this study, we examined whether serotoninergic modulation influences the accuracy 
of personality inferences, as cued by neutral facial expressions.  
 
Research on trait inferences shows that observers can identify personality and other 
important social traits, with modest levels of accuracy, using only impoverished 
cues. For example, Borkenau and Liebler (1992) established that, even at zero-
acquaintance, observers could draw accurate personality inferences from short video 
clips of an individual walking into a room, or quietly facing the camera. Such 
nonverbal thin slices of behaviour can be famously diagnostic of consensual longer-
term impressions; for example, teachers' end-of-semester ratings can be predicted 
from judges reactions to a few seconds of silent video clips of those teachers 
(Ambady & Rosenthal, 1992; 1993). While accurate trait inferences can be drawn on 
the basis of very short exposures (Borkenau et al, 2009; Rule et al, 2009), accuracy is 
also affected by the quantity and quality of cues available (Funder & Colvin, 1988; 
Carney, Colvin, Hall, 2007). In particular, the availability of other cues under 
individuals control  such as their hairstyles, clothing, cosmetics, and facial 
expressions  can improve accuracy of trait judgements (Nauman et al, 2009). 
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However, even when controllable cues are minimal, facial appearance under 
constrained and standardised conditions (such as in a passport photograph) can drive 
accurate trait inferences. Emotionally neutral facial appearances, without evident 
clothing, cosmetics, or hairstyle cues, can allow accurate judgements of socially-
relevant traits as diverse as trustworthiness (Stirrat & Perrett, 2010), women's 
reproductive success (Pflüger et al, 2012) and even clinically-diagnosed borderline 
personality disorder (Daros, Ruocco, & Rule, 2016). The accuracy of trait inferences 
based upon neutral faces suggests an important, but under-explored, channel of 
social communication in which individuals continuously and involuntarily broadcast 
cues about behavioural predispositions to observers and potential social partners. 
 
Of primary interest for the present study are findings that factor-analytic personality 
traits, and in particular trait Neuroticism, can be identified from composite images of 
neutral facial appearance (e.g., Little & Perrett, 2007; Kramer & Ward, 2010; Jones, 
Kramer, & Ward, 2012). Neuroticism is marked by a tendency towards fearful 
emotions, including anxiety, depression, fear, and worry (Vinberg, Miskowiak, & 
Kessing, 2014; McWilliams, 2003). Neurotic traits are also related to the frequency 
and intensity of negative emotions (Verduyn & Brans, 2012). Of all the big five 
personality traits, Neuroticism would be the most closely related to fear (Nettle, 
2006). Given that serotonin plays an important role in the recognition of emotional 
expressions and, in particular, fearful states (e.g., Harmer et al, 2003), we 
hypothesised that serotonin activity plays a role in identifying trait Neuroticism from 
the face. We therefore investigated, for the first time, the role of serotonergic activity 
in making accurate personality discriminations from facial appearance cues. We 
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tested the specific prediction that tryptophan depletion impairs accurate identification 
of Neuroticism from neutral facial expressions in healthy adult volunteers. 
 
Method 
The experiment was approved by a National Health Service (England) Research 
Ethics Committee. All participants provided informed consent. 
 
Participants 
Fifty-three males and females were recruited from the student population of Oxford 
University and local community. One female was excluded on the basis of 0% 
accuracy in discriminating Neuroticism (3.7 SDs from her group mean). No other 
participant had 0% accuracy. Participants were assessed by an experienced 
psychiatrist against explicit exclusion criteria using the Structured Clinical Interview 
for DSM-IV-TR Axis I Disorders (First, Spitzer, Gibbon, & Williams, 2002). 
 
Exclusion criteria included (i) the presence or history of serious physical illness; (ii) 
history of neurological disorder or head injury; (iii) current, previous or family 
history of mood-related illness (unipolar or bipolar disorder); (iv) current or previous 
substance misuse or dependence; (v) other significant psychiatric illness; (vi) any 
illness or indicators that preclude blood-sampling; (vii) pregnancy or breast-feeding. 
 
Design 
The study consisted of a between-subjects, double-blind design. Twenty-five 
participants (10 men, 15 women) were randomly selected to consume an amino-acid 
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drink without l-tryptophan (T- treatment), and 27 participants (16 men, 11 women) 
were to consume an amino-acid drink with l-tryptophan (T+ treatment). 
 
Materials 
Amino acids. Amino acids were supplied by Nutricia or Cambridge Bioscience. 
Amounts for males and females, respectively, were:- l-alanine (5.5g;4.58g), l-
arganine (4.9g;4.08g), l-cystine (2.7g;2.25g), glycine (3.2g;2.67g), l-isoleucine 
(8.0g;6.67g), l-leucine (13.5g; 11.25g), l-lysine monohydrochloride (11.0g; 9.17g), l-
methionine (3.0g; 2.5g), histidine (3.2g;2.67g); l-phenylalinine (5.7g;4.75g), l-
proline (12.2 g;10.17 g),l-serine (6.9g;5.75g),l-threonine (6.5g;5.42g),l-tyrosine 
(6.9g;5.75g), l-valine (8.9 g;7.42 g). The T + drink contained l-tryptophan 
(2.3g;1.92g). Tastes were masked with 5g (15cals; 1.3g carb.) of citric (or malic) 
acid (cherry-and-vanilla or grapefruit) and artificial sweetener. 
 
Psychometric Assessments. Following the screening interview, participants 
completed the (i) trait and state Positive and Negative Affect Scales (Watson, Clark 
& Tellegen, 1988); (ii) Beck's Depression Inventory (BDI-II) (Beck, Steer & Brown, 
1996) and (iii) Buss-Perry Aggression Questionnaire (Buss & Perry, 1992). The 
PANAS consists of two subscales of 20 items, rated using a 5-point Likert scale, to 
measure positive and negative aspects of emotional experience. Cronbach's α 
coefficients for the state (i.e. momentary) version of the positive affect and negative 
affect subscales have been reported as .90 and .87, respectively (Watson et al, 1988).  
The BDI-II consists of 21 statements that capture the frequency of depressive 
symptoms over the previous 14 days, with total scores tested against cut-offs to 
indicate minimal to severe depression (Beck et al, 1996). It has strong convergent 
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and criterion reliability. A Cronbach's α coefficient of 0.94 indicates high internal 
consistency (Arnau, Meagher, Norris & Bramson, 2001). Finally, our participants 
completed the Standard Progressive Raven's Standard Progressive Matrices to assess 
non-verbal cognitive ability (Raven, Raven & Court, 2004). 
 
Personality Trait Discrimination Task 
The trait discrimination task used composites of female faces, reflecting the 
correlated facial appearance of women who share similar levels of personality traits 
(e.g., Kramer & Ward, 2010; Jones et al, 2012). We used the full-face stimulus set 
created by Kramer and Ward (2010), which was made by averaging neutral face 
photos from women scoring highest and lowest on self-report measures of each big 
five personality traits (Agreeableness, Openness, Conscientiousness, Extraversion 
and Neuroticism), as measured on the Mini International Personality Item Pool 
(Mini-IPIP, Donnellan, Oswald, Baird, & Lucas, 2008). Thus, the composite face 
pairs reflected regularities in facial appearance which are correlated with specific 
personality traits. In addition, the stimuli set included two composites which were 
not based upon the Big Five traits: physical health (used by Kramer & Ward, 2010); 
and a single presentation based upon depressive symptoms (as described by Scott et 
al, 2013). These composites were presented once in each stimulus set, providing 
insufficiently reliable patterns of discriminations; they are not discussed further. 
 
On each presentation (hereafter, trial), one high and one low composite for a 
personality trait were presented, randomly positioned on either side of centre on a 
standard computer display, along with a discrimination statement relevant to that trait 
(e.g., 'More prone to mood swings' for trait Neuroticism, see Figure 1). Participants 
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made an unspeeded mouse-click on the face best matching the discrimination 
statement. Each trait was presented four times, using four different discrimination 
statements (items) adapted directly from the Mini-IPIP (Donnellan et al, 2008). 
 
Figure 1. Face stimuli and example discrimination statements for (a) Agreeableness; 
(b) Extraversion; and (c) Neuroticism. In each case, the face on the left is a 
composite of 15 women scoring highest on the trait measure, and the face on the 
right a composite of 15 women scoring lowest on that measure (see Kramer & Ward, 
2010 for details). Participants were asked to identify which of the two faces best 
matched the accompanying discrimination statement.  
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Procedure 
All participants followed a low-protein diet for 24hr before ingesting an amino-acid 
drink on the morning of the experiment. On arrival at the laboratory, participants 
completed baseline ratings of state positive and negative affect using the PANAS 
(Watson et al, 1988). Blood samples (6 ml) were taken for baseline measurements of 
plasma tryptophan levels and tryptophan/LNAA ratios. Participants then ingested 
their allocated amino acid drinks. Five hours later (+5hr), participants provided 
follow-up ratings of state affect with the PANAS, as well as a second blood sample. 
Participants then completed cognitive assessments and social exchange games that 
included the computerized trait discrimination task reported here.  
 
Data Analysis 
Differences in the number of males and female participants in the T- and the T+ 
groups were tested with χ2 tests. Group-matching of age, cognitive ability (scored 
with the Raven's Standard Progressive Matrices; Raven et al, 2004), trait affect 
(scored with the Positive and Negative Affect Scale; Watson et al, 1988); and recent 
depressive symptoms (scored with the Beck Depression Inventory II; Beck et al, 
1996) were tested with two-sample t-tests. Changes in total plasma tryptophan, the 
ratio of plasma tryptophan to other large neutral amino acids (LNAAs), and state 
positive and negative affect (as measured by the PANAS) were assessed by separate 
repeated measures ANOVAs with the single between-subject factor of treatment (T- 
vs T+) and the within-subject factor of time (baseline vs +5 hr).  
 
Using the same full-face stimuli as here, Kramer & Ward (2010) demonstrated that 
healthy young adults (comparable to our participants) are able to discriminate 
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reliably Neuroticism, Extraversion and Agreeableness but not Openness or 
Conscientiousness. Similar accuracy levels of trait discrimination are reported by 
Kramer & Ward (2011) using hemi-face versions of these stimuli (that is, presenting 
just the left or right half of the stimuli). Therefore, we focused our analyses upon the 
most robustly discriminated traits of Neuroticism, Extraversion, and Agreeableness. 
First, we used 1-sample t-tests to assess all participants' discrimination accuracy 
against chance (0.5) and 2-sample t-tests to test the prediction that T- participants 
were less accurate in discriminating Neuroticism and, perhaps, other traits compared 
to T+ participants. Fifty-two participants provide a statistical power of approximately 
0.8 at α= .05 (one-sided) to detect medium effect sizes (0.5) in the 1-sample t-tests 
and medium-to-large effect sizes (0.7) in the 2-sample tests.  
 
As per standard practice (Rogers, Tunbridge, Bhagwagar, Drevets, Sahakian, & 
Carter, 2003; Bilderbeck, Brown, Read, Woolrich, Cowen, Behrens, & Rogers, 
2014), the T- and T+ participants were carefully matched for demographic and 
psychometric variables: sex; age; depressive symptomology (BDI-II; Beck et al, 
1996); trait affect (PANAS; Watson et al, 1988), aggression (Buss & Perry, 1992); 
and cognitive ability (Raven's Standard Progressive Matrices; Raven et al, 2004). 
 
Since this is the first study of the effects of tryptophan depletion upon the 
discrimination of personality traits from the face, we also used a mixed-effects 
binomial model (Bates, 2010) to test effects of these variables upon discrimination 
on the individual trials, and examine whether their inclusion in the model moderated 
the reliability of the treatment effects. The model included random intercept terms 
for participant and for item, and a random slope for treatment by item; and fixed 
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effects for the remaining predictors, comprising tryptophan depletion, and the 
demographic and psychometric variables above. All non-categorical predictors (i.e., 
other than sex and treatment) were zero-centered and scaled to variance of 1. 
 
Results 
The demographic and psychometric characteristics of the T- and T+ participants are 
shown in Table 1. The groups were closely matched for age, cognitive ability (as 
measured by the Raven's Progressive Matrices (Raven et al, 2004)), recent 
depressive symptoms (as measured by the BDI (Beck et al, 1996)), trait positive and 
negative affect (as measured with the trait version of the PANAS (Watson et al, 
1988)) and trait aggression (Buss & Perry, 1992), all t(50)< 2.0. 
 
 T- participants T+ participants 
Sex (Male: Female) 10:15 16:11 
Age 25.2 (1.21) 24.1 (1.20) 
Depressive symptoms (BDI)  0.68 (0.34) 1.30 (0.30) 
Trait +ve affect (PANAS)   37.5 (1.38) 35.9 (1.15) 
Trait –ve affect (PANAS)  11.4 (0.39) 12.9 (0.83) 
Total Aggression (Buss-Perry)   44.4 (2.16) 50.3 (2.18) 
Raven’s Matrices   53.4 (0.69) 54.4 (0.76) 
Plasma trypt. (µg/ml) 0hr 10.2 (0.39) 10.4 (0.38) 
Plasma trypt. (µg/ml) +5hr   4.0 (0.68) 21.2 (1.11) 
Tryptophan LNAA ratio 0hr 0.14 (0.01) 0.14 (0.01) 
Tryptophan LNAA ratio +5hr 0.03 (0.01) 0.16 (0.01) 
State +ve affect (PANAS) +0 hr   28.2 (1.66) 29.0 (1.41) 
State +ve affect (PANAS) +5hr 27.2 (1.58) 29.0 (1.59) 
   
State -ve affect (PANAS) +0 hr 12.2 (0.57) 12.6 (0.45) 
State -ve affect (PANAS) +5 hr 11.5 (0.58) 11.1 (0.27) 
 
Table 1. Demographic and psychometric characteristics, plus tryptophan 
measurements, of 25 healthy adults who completed a tryptophan depletion protocol 
and consumed an amino acid drink without tryptophan (T- participants) and 27 
heathy adults who consumed an amino acid drink that did contain tryptophan (T+ 
participants). Beck's Depression Inventory (BDI-II; Beck et al, 1996); trait and state 
Positive and Negative Affect Schedule (PANAS; Watson et al, 1988); Raven’s 
Matrices (Raven et al, 2004); and Aggression Questionnaire (Buss & Perry, 1992). 
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As expected (Moore et al, 2000), plasma total tryptophan concentrations showed 
significant divergence between baseline and +5hr in the T- and T+ participants (see 
Table 1), F(1,45)=170.1, p<.00001. Specifically, total tryptophan decreased in the T- 
participants from 10.2 ug/ml to 4.0 ug/ml, t(22)=7.20, p<.00001, but increased in the 
T+ participants from 10.4 to 21.2 ug/ml, t(23)=11.09, p<.00001. (Note: 3 T+ and 2 
T- participants were excluded from these tests because of missing blood samples in 
the morning or afternoon). The ratio of plasma tryptophan to other large neutral 
amino acids (LNAAs) also showed different changes following the T- and T+ drinks 
(see Table 1), F(1, 45)=69.6, p< .00001. Here, however, only the tryptophan/LNAA 
ratios following the T- treatment were reduced from .14 to .03, t(22)=10.4, 
p<.00001; but the change from .14 to .16 following the T+ treatment was not 
significant, t(23)=1.28, p=.215. At +5hr, both plasma tryptophan and the 
tryptophan/LNAA ratios were reduced in the T- participants compared to the T+ 
participants, t(45)=12.4, p<.00001, and t(45)=11.0, p<.00001, respectively. 
 
Overall, participants' state negative affect (as scored by the PANAS; Watson et al, 
1988) showed a significant decline between baseline and +5hr (see Table 1), F(1, 
50)= 12.0, p< .002. State positive affect was unchanged, F(1, 50)< 1. Tryptophan 
depletion did not produce any marked differential changes in either participants' state 
positive or state negative affect (see Table 1); all Fs(1, 50)< 1.6, all ps> 0.2.  
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Figure 2. Mean proportionate accuracy on the two-alternative forced-choice trait 
discrimination of Agreeableness, Extraversion, and Neuroticism in 27 heathy 
participants who consumed an amino acid drink that did contain tryptophan (T+ 
participants), and 25 healthy adult participants who had consumed an amino acid 
drink without tryptophan (T- participants). Error bars represent 1 standard error.  
 
Trait accuracy: Overall, and consistent with Kramer & Ward (2010), participants 
discriminated Neuroticism with significantly greater accuracy than chance by a 1-
sample t-test, M=.70, SE=.035, t(51)=5.7, p<.0001, d = .79. This was also true of 
Extraversion, M=.75, SE=.038, t(51)=6.65, p<.0001, d=.92, and Agreeableness, 
M=.63, SE=.042, t(51)=3.09, p=.003, d=.43. Like Kramer & Ward (2010), our 
participants were not able to discriminate Openness reliably, M=.50, SE=.037, 
t(51)=.13, p=.9, d=.02, but unlike Kramer and Ward (2010), they were able to 
discriminate Conscientiousness, M=.60, SE= .036, t(51)=2.8, p=.008, d=.38. 
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Separate comparisons showed that the T- participants showed significantly poorer 
discrimination of Neuroticism compared to the T+ participants by a 2-sample t-test 
(see Figure 2), t(50)=2.23, p=.030, d=.62. By contrast, the discrimination accuracies 
of the T- participants showed no significant changes compared to the T+ participants 
for both Extraversion and Agreeableness (see Figure 2) or indeed Openness and 
Conscientiousness (see Table 2), all ts(50)<1, ps> .3, d<.26).   
 
 T- participants T+ participants 
Agreeableness 0.63 (0.056) 0.63 (0.063) 
Extraversion 0.75 (0.056) 0.75 (0.052) 
Neuroticism 0.62 (0.054) 0.77 (0.040) 
Conscientiousness  0.57 (0.059) 0.63 (0.045) 
Openness         0.47 (0.056) 0.54 (0.048) 
   
Table 2. Mean discrimination accuracy (together with their standard errors) for 
Openness and Conscientiousness in 25 healthy adults who had completed a 
tryptophan depletion protocol and consumed an amino acid drink without tryptophan 
(T- participants) and 27 matched heathy adults who had consumed an amino acid 
drink that did contain tryptophan (T+ participants). 
 
Discrimination accuracy for Neuroticism was examined in detail by analysis with a 
binomial mixed-effects model (Bates, 2010) (see Table 3). Female participants 
showed lower accuracy than male participants, β= -0.796, SE= 0.360, p= 0.027; and 
the T- participants showed significantly lower accuracy in identifying neurotic faces, 
β= -0.934, SE= .358, p= 0.0091). No significant effect was found for other predictors 
(all βs< 0.33). The effect of treatment was numerically larger for women than men 
(T+: women=.75, SE=.058; men= .78, SE=.055; T-: women=.55, SE=.065, 
men=.725, SE=.087). However, an additional treatment*sex interaction term was not 
significant, β= 0.332, SE=0.699, and did not improve the model, χ2(1)=0.21. 
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(Intercept) 1.00 (.375) 
Sex (male = 0; female =1)   -.796 (.360) * 
Age .131 (.190) 
Buss-Perry Total -.327 (.210) 
BDI .061 (.193) 
Trait PANAS +ve -.047 (.166) 
Trait PANAS -ve -.267 (.189) 
Ravens .004 (.178) 
Treatment (T+ = 0; T- = 1)      -.934 (.358) ** 
 
Table 3. Mixed-effects binomial modelling of discrimination on Neuroticism trials. 
Standardised weighting (standard error) for non-categorical factors. 
 
 
Discussion 
To our knowledge, this is the first demonstration that serotonin activity supports the 
perceptual discrimination of personality. These findings show that tryptophan 
depletion -- producing temporary reductions in central serotonin activity (Moore et 
al, 2000; Bilderbeck et al, 2014) -- diminishes the capacity of healthy adults to 
discriminate Neuroticism, but not other traits, in other people on the basis of facial 
cues. The T- and the T+ participants were closely matched in terms of sex, age and 
cognitive ability. Consistent with previous studies involving healthy adult volunteers 
with no personal or family history of depression (Rogers et al, 2003; Bilderbeck et al, 
2014; Wood et al, 2006), there were no marked differences between our T- 
participants and T+ participants in terms of their state positive or negative affect, 
either before or following consumption of the amino acid drinks.    
 
Our findings expand our understanding of serotoninergic mechanisms in processing 
of emotional and social signals in other people. Substantial evidence attests to the 
monoaminergic modulation of emotional recognition in the face (Walsh & Harmer, 
2015) and the processing of other appetitive and aversive signals (Boureau et al, 
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2011; Crockett et al, 2012; Hindi Attar, Finckh & Buchel, 2012). Neuroticism is 
strongly associated with fearfulness and vulnerability to anxiety, depression and 
negative rumination (Fergusson, Horwood, & Lawton, 1989; Nettle, 2006; Vinberg, 
Miskowiak, & Kessing, 2014; Verduyn & Brans, 2012). Thus, our finding that 
tryptophan depletion impairs the accuracy of Neuroticism discrimination suggests 
that serotonergic activity mediates the ability to discriminate subtle cues that signal 
vulnerability to psychological distress in the absence of expressed negative emotion. 
 
Serotonergic mechanisms influence the expression of social behaviours in both 
humans (Knutson et al,1998; Moskowitz et al, 2001; Tse & Bond, 2002; Young & 
Leyton, 2002) and non-human primates (Raleigh et al, 1981; Raleigh et al, 1985) 
and, in particular, a wide variety of social exchanges with partners and group 
members (Colzato et al, 2013; Higley et al, 1996; Crockett et al, 2012; Crockett et al, 
2008; Wood et al, 2006; Bilderbeck et al, 2014). Twelve days administration of 
tryptophan in healthy (non-clinical) adults decreases (perceived) quarrelsomeness 
and increases dominance (Moskowitz et al, 2001; 2003). The present findings 
suggest that serotonergic influences over social behaviours also incorporate the 
moderation of sensitivity to the facial signals of vulnerability to distress in (potential 
or actual) social partners. Important social behaviours  for example, the selection 
of mates and the pursuit of affiliative relationships  are influenced by the 
perception and then the appraisal of facial appearances (e.g. Rhodes, 2006). The 
present data indicate that serotonergic activity mediates these behaviours by its 
contribution to perceptual sensitivity to cues of psychological vulnerability. 
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These results also raise the possibility that psychological disorders, such as 
depression, whose pathophysiology includes serotonergic dysfunction (Bhagwagar & 
Cowen, 2008; Bhagwagar & Cowen, 2008; Cowen, 2008) are associated with 
mistaken inferences about other peoples' personalities, especially around 
vulnerability to psychological distress and illness. Accurate discrimination of mental 
health can be accompanied by other negative and potentially incorrect inference. For 
example, Scott et al (2013) and Daros et al (2016, Study 2A) report high levels of 
accuracy in judging depressive symptoms from facial expressions but, importantly, 
the faces of individuals with poor mental health were mistakenly judged as lower in 
warmth and friendliness (Scott et al, 2013), and more negatively in their emotional 
expressions (Daros et al, 2016). To the extent that depressive symptoms are mediated 
by serotonergic dysfunction (Bhagwagar & Cowen, 2008; Cowen, 2008), there may 
be a cycle of psycho-pathogenic effects: (1) healthy observers mistakenly appraise 
depressive individuals with negative characteristics (Coyne, 1976); and (2) serotonin 
dysfunction in depression triggers misidentification of personality of others. 
Together these misperceptions may disrupt social relationships in depressed people.  
 
Tryptophan depletion had no marked effects upon the discrimination of other big-
five traits shown to our participants (Agreeableness, Extraversion and Openness or 
Conscientiousness), suggesting that serotonin activity plays a particular role in the 
discrimination of Neuroticism. The specificity of the effects of tryptophan depletion 
reported here also help to rule out a single mechanism for personality discrimination 
such as, for example, the selection of the more attractive of the two composites 
presented as the more desirable characteristic (i.e., highly Agreeable, Extraverted, 
and Stable). Rather, our data suggest that, like the discrimination of emotional 
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expressions (e.g. Calder & Young, 2005), trait inference based upon facial 
characteristics depends upon mechanisms that are dissociable across traits. Future 
investigation will need to delineate the extent to which discrimination of personality 
from the face share cognitive and neurochemical substrates with the discrimination 
of emotional expressions (c.f. serotonin and noradrenaline; Harmer et al, 2004). 
 
The present study used the same stimuli and, broadly, replicates the findings of 
Kramer and Ward (2010) and, in particular, the accurate discrimination of full-face 
composites for the traits Agreeableness, Extraversion, and Neuroticism. In contrast, 
to Kramer and Ward, our participants had completed a protocol that included dietary 
(protein) restriction, a full day of testing, and consumption of amino acid drinks. 
Collectively, these two datasets, therefore, suggest some robustness in the accuracy 
of individuals' discrimination of these stimuli. However, in contrast to Kramer and 
Ward (2010), our participants showed significantly better than chance discrimination 
of Conscientiousness. Therefore, at present, we cannot be certain about the 
consistency of Conscientiousness identification across study protocols or participant 
populations, and are reluctant to draw strong conclusions about the absence of 
changes in Conscientiousness discrimination following tryptophan depletion.  
  
In these data, women were significantly less accurate than men in the discrimination 
of Neuroticism. This is unusual, as women are often found to be more sensitive than 
men in trait inference tasks, and are rarely found to be worse (e.g., Hall & Mast, 
2008). This unusual outcome probably reflects the differential effects of the 
tryptophan depletion across sexes. Tryptophan depletions cognitive and emotional 
effects are often greater for women than for men (Booij et al, 2005), including effects 
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upon the recognition of fearful expressions (Harmer et al, 2003). Sex differences 
involving tryptophan depletion may reflect differences in hormonal activity or the 
distribution of receptors (Fehr et al, 2000; Zhang et al, 1999). Here, although not 
statistically significant, impaired discrimination of Neuroticism following tryptophan 
depletion was numerically more marked in the women than men. Therefore, the 
significant main effect of sex upon Neuroticism discrimination accuracy may reflect 
only the greater impact of depletion upon women's accuracy for neuroticism.  
 
Finally, changes in the recognition of facial expressions of emotion following single 
treatments of serotonergic or noradrenergic anti-depressants (Bhagwagar et al, 2004; 
Browning et al, 2007) appear to form part of a complex of cognitive adjustments that 
presage the therapeutic effects upon mood following continued treatment in clinical 
populations (Walsh & Harmer, 2015). Further experimentation with tryptophan 
loading protocols (Murphy et al, 2006; 2009), single or sub-chronic treatments with 
anti-depressants could indicate whether the accuracy of Neuroticism inferences from 
the face can be improved by enhancing serotonergic activity and other personality 
inferences in treated and untreated depressed patients. Similarly, trait inferences 
about potential social partners may regulate approach and withdrawal behaviours, 
highlighting the issue of how serotonergic modulation of these judgements relates to 
the activity of the inter-dependent peptide systems implicated in both mood and 
social bonding, such as oxytocin (Dolen, 2015; Flight et al, 2013).  
 
Notwithstanding these future possibilities, these data provide preliminary evidence 
that transient reductions in serotonin activity, produced by tryptophan depletion, 
impair the discrimination between high versus low Neuroticism on the basis of facial 
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cues. These findings suggest that serotonin activity modulates the detection of 
physical signals of vulnerability to depression and psychological distress.  
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